Genomic score predicts patients' progression to multiple myeloma
Broad Institute
MAY 21, 2025
To make the MM-like score more clinically accessible, the team is developing a test based on liquid biopsies instead of bone marrow biopsies to collect DNA. The score, called an MM-like score, assesses the severity of disease and risk of progression to active cancer, with higher scores indicating faster progression.
Let's personalize your content